PICO Portalanswers from OpenAlex & ORCID
Nanwei Tong
ResearcherPublications, citations & collaboration network
Nanwei Tong is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Nanwei Tong have?
PICO Portalindexed works
Nanwei Tong has 19 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nanwei Tong have?
PICO Portalcitation count
Nanwei Tong has 648 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Nanwei Tong?
PICO Portalh-index
Nanwei Tong has an h-index of 6 in OpenAlex.
What is the i10-index of Nanwei Tong?
PICO Portali10-index
Nanwei Tong has an i10-index of 4 in OpenAlex.
What is the ORCID of Nanwei Tong?
PICO Portalorcid
The ORCID for Nanwei Tong is on the source record.
What is the OpenAlex record for Nanwei Tong?
PICO Portalopenalex
The OpenAlex for Nanwei Tong is on the source record.
What are the most-cited papers on Nanwei Tong?
PICO Portalmost cited works
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Xi Lu, Qingxing Xie, Xiaohui Pan, Ruining Zhang, Xinyi Zhang, Ge Peng, Yuwei Zhang, Sumin Shen, Nanwei Tong
Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials
Juan Li, Yuzhen Tong, Yuwei Zhang, Lizhi Tang, Qingguo Lv, Fang Zhang, Ruijie Hu, Nanwei Tong
Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials
Xinyue Zhang, Yuqi Liu, Fang Zhang, Juan Li, Nanwei Tong
Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto–Kakizaki Rats from Lipoapoptosis <i>via</i> GPR40
Juan Li, Shishi Xu, Yuqi Liu, Zhe Yan, Fang Zhang, Qingguo Lv, Nanwei Tong
Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events
Yuchao Wu, Lizhi Tang, Fang Zhang, Zhe Yan, Jing Li, Nanwei Tong